UnknownPhase 2NCT00882323

Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Korean Society of Pediatric Hematology Oncology
Principal Investigator
Hyo seop Ahn, M.D, Ph. D, LCSW
The Korean Society of Pediatric Hematology Oncology
Intervention
Cyclophosphamide, Fludarabine, Thymoglobulin(drug)
Enrollment
33 enrolled
Eligibility
1-21 years · All sexes
Timeline
20082012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00882323 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia

← Back to all trials